biogenBiogen started out as a penny stock like TST...they have approximately 222 million shares outstanding...they don't have an "out of the park" drug...but over the span of its life they have grown to a 50billion dollar market cap(currently trading at $268 dollars and a high of $480 dollars...)
the only differ between tst and biig is the shares outstanding...we have approximately 28% more O.S I can't seem to wonder that tst will follow in biib's footsteps and be a 30-50 billion market cap in ten years sooner or later...gltal
red